Literature DB >> 20973240

[Study of serotype distribution, antimicrobial resistance patterns and molecular epidemiology in 148 isolates of invasive Streptococcus pneumoniae].

Chun-Lin Liu1, Chun-Jiang Zhao, Yu-Dong Liu, Hui Wang.   

Abstract

OBJECTIVE: To investigate the serotype distribution, antimicrobial resistance patterns and molecular epidemiology of Streptococcus pneumoniae (S. pneumoniae) isolated from invasive pneumococcal diseases in order to provide rationales for antibiotics application and immunity control of S. pneumoniae.
METHODS: A total of 148 isolates of invasive S. pneumoniae were collected from blood, cerebrospinal fluid and other sterile body fluids from 15 regions between January 2005 and August 2008 nationwide. Agar dilution method was used to determine the minimal inhibitory concentrations (MICs) of penicillin and other antibiotics against these isolates. Simplified chessboard system and capsule swelling reaction were used for serotyping of S. pneumoniae. Multilocus sequence typing (MLST) was used to determine the genetic relationship of 53 strains of serogroup-19.
RESULTS: Twenty serotypes/serogroups were identified in 148 strains. The prevalent serotypes (70.9%) were 19A, 19F, 3, 23F, 5, 6, 14 and 9 respectively. Serotypes 19A (22.3%, 33/148) and 19F (16.9%, 25/148) were the most frequent type observed. And serotypes 3 (7.4%, 11/148) and 23F (6.8%, 10/148) were less prevalent. Of all 36 strains isolated from infants under 2 years old, 33.3% (12/36) were covered by 7-valent pneumococcal conjugate vaccine (PCV7). The resistant rates to amoxicillin/clavulanic acid, erythromycin and other antibiotics in PCV7-related pneumococcal strains were significantly higher than those in PCV7-unrelated group (P < 0.05). Fifty-three strains of serogroup-19 were genotyped by MLST and 9 sequence types (STs) identified. ST320 (52.8%, 28/53) and ST271 (22.6%, 12/53) were the most frequent STs.
CONCLUSIONS: The major serotypes of invasive S. pneumoniae are 19A, 19F, 3 and 23F. Antimicrobial-resistant S. pneumoniae has become a serious issue of public health.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20973240

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  6 in total

Review 1.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

Review 2.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

3.  Molecular Characterization of Penicillin-Binding Protein2x, 2b and 1a of Streptococcus pneumoniae Causing Invasive Pneumococcal Diseases in China: A Multicenter Study.

Authors:  Menglan Zhou; Lulu Wang; Ziran Wang; Timothy Kudinha; Yao Wang; Yingchun Xu; Zhengyin Liu
Journal:  Front Microbiol       Date:  2022-03-01       Impact factor: 5.640

4.  Genotype replacement within serotype 23F Streptococcus pneumoniae in Beijing, China: characterization of serotype 23F.

Authors:  X Ma; K H Yao; S J Yu; L Zhou; Q H Li; W Shi; M M He; Y H Yang
Journal:  Epidemiol Infect       Date:  2012-10-16       Impact factor: 4.434

5.  Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis.

Authors:  Kaile Chen; Xiyan Zhang; Wei Shan; Genming Zhao; Tao Zhang
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 4.526

6.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: a meta-analysis.

Authors:  Jinjian Fu; Rongsong Yi; Yongjiang Jiang; Shaolin Xu; Peixu Qin; Zhuoxin Liang; Jichang Chen
Journal:  BMC Pediatr       Date:  2019-11-11       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.